Skip to NavigationSkip to content

Sanofi launches ‘Monster Manor’ diabetes app

Published on 23/10/13 at 11:22am
Monster manor image

Sanofi has launched a new healthcare app called Monster Manor to help children with type 1 diabetes better manage their condition.

Sanofi Diabetes developed the app alongside Ayogo Health and Diabetes UK, in an effort to encourage children to test and record their blood glucose levels on a more regular basis.

With only 15% of children managing to achieve their blood glucose targets, the partners hope that this app can make a difference to the way they manage their diabetes.

Sanofi currently makes some of the world’s biggest-selling insulin products for type 1 diabetes, and has expressed its desire to become the biggest diabetes drugmaker in the world.

It also launched an iPhone-compatible iBGStar meter to help people read and track their blood sugar levels in 2012, so this latest game will add to its digital diabetes footprint.

Children between the ages six and 13 with type 1 diabetes are expected to take on increasing responsibility for testing and logging their own blood glucose.

Monster Manor aims to provide a fun and rewarding experience for those children who struggle with this growing responsibility. It works via a system of gamification by rewarding those with gifts and prizes within the game if they test regularly.

Research shows that just one extra test a day in teenagers leads to a 0.4% reduction in blood sugar levels (or HbA1c), which could be very significant.

Michael Fergusson, chief executive at Ayogo Health said: “As game designers, watching children play Monster Manor has been very satisfying, as the kids tell us that it’s fun and they want to keep playing. But for us, fun is only a means to an end; the goal ultimately is to improve health outcomes for the children we work for.”

Simon O’Neill, director of Health Intelligence and Professional Liaison at Diabetes UK, said: “By turning the testing into a game we hope it will encourage young children with diabetes to manage their condition more effectively and help them succeed in achieving tighter blood glucose control in their early years. In turn this would help them reduce th